182 related articles for article (PubMed ID: 6364088)
1. Cephalexin in lower respiratory tract infections.
Raff MJ
Postgrad Med J; 1983; 59 Suppl 5():32-9. PubMed ID: 6364088
[TBL] [Abstract][Full Text] [Related]
2. Cephalexin in the treatment of upper respiratory tract infections.
Disney FA
Postgrad Med J; 1983; 59 Suppl 5():28-31. PubMed ID: 6364087
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactam antibiotics in lower respiratory tract infections.
Schreiner A
Scand J Infect Dis Suppl; 1984; 42():129-34. PubMed ID: 6597558
[TBL] [Abstract][Full Text] [Related]
4. Cephalexin in lower respiratory infections.
Practitioner; 1972 Mar; 208(245):421-3. PubMed ID: 4554484
[No Abstract] [Full Text] [Related]
5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
6. Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
Iancu TC; Sinoff G
Isr J Med Sci; 1983 Nov; 19(11):998-1000. PubMed ID: 6662693
[TBL] [Abstract][Full Text] [Related]
7. Cephalexin: clinical effectiveness in geriatric patients.
Smith IM
Geriatrics; 1977 Mar; 32(3):91-5, 99. PubMed ID: 844692
[TBL] [Abstract][Full Text] [Related]
8. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cepharadine and cephalexin in the treatment of respiratory and urinary tract infections.
Mogabgab WJ
Curr Ther Res Clin Exp; 1976 Apr; 19(4):421-32. PubMed ID: 4284
[No Abstract] [Full Text] [Related]
11. The pharmacology of cephalexin.
Griffith RS
Postgrad Med J; 1983; 59 Suppl 5():16-27. PubMed ID: 6364086
[TBL] [Abstract][Full Text] [Related]
12. Managing acute lower respiratory tract infections in an era of antibacterial resistance.
Volturo GA; Low DE; Aghababian R
Am J Emerg Med; 2006 May; 24(3):329-42. PubMed ID: 16635707
[TBL] [Abstract][Full Text] [Related]
13. Barriers to the effective management of respiratory tract infections in the community.
Saginur R
Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of pulmonary infections with cephalexin (author's transl)].
Götz M; Klabuschnigg A
Padiatr Padol; 1978; 13(2):221-5. PubMed ID: 643299
[TBL] [Abstract][Full Text] [Related]
15. Drug resistant Haemophilus influenzae from respiratory tract infection in a tertiary care hospital in north India.
Nag VL; Ayyagari A; Venkatesh V; Ghar M; Yadav V; Prasad KN
Indian J Chest Dis Allied Sci; 2001; 43(1):13-7. PubMed ID: 11370501
[TBL] [Abstract][Full Text] [Related]
16. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
Cantón R; Lode H; Graninger W; Milkovich G
Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S115-27. PubMed ID: 16904873
[TBL] [Abstract][Full Text] [Related]
17. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
Sader HS; Jones RN
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451
[TBL] [Abstract][Full Text] [Related]
18. [Cephalexin in pulmonary infections in children].
Paschetta G; De Biasi V
Minerva Pediatr; 1971 Dec; 23(49):2065-71. PubMed ID: 5131194
[No Abstract] [Full Text] [Related]
19. [Efficacy of cefadroxil in acute and chronic bacterial infections of the respiratory tract].
Nosenzo M; Razzetti A; Delle Piane M; Faravelli B; Suffritti G
Clin Ter; 1983 Mar; 104(5):383-9. PubMed ID: 6342913
[No Abstract] [Full Text] [Related]
20. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
Silvia G; Giambrone F; Battaglia E; Romano M
G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
